Skip to main content
    P

    Precigen Inc (PGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.30
    -0.24 (-5.29%)

    Market Cap: $1.63B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Precigen Inc (PGEN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Precigen reported revenue of $9.68M for the fiscal year ended Dec 31, 2025, up 146.7% from the year before. That year, net income was -$250.64M with a net margin of -2588.2%, operating cash flow was -$87.83M and free cash flow was -$89.83M. The quarter ended Sep 30, 2026 had revenue of $74.15M and net income of $35.77M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue fell from $190.93M, a compound annual decline of 28.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$9.68M+146.7%50.2%-1141.1%-2588.2%
    Dec 2024$3.92M-36.9%-8.7%-3440.2%-3216.2%
    Dec 2023$6.22M-76.9%1.7%-1602.5%-1540.6%
    Dec 2022$26.91M+88.6%76.4%-281.4%130.4%
    Dec 2021$14.27M-55.4%59.7%-644.5%-646.0%
    Dec 2020$31.99MN/A83.2%11.4%-198.5%
    Dec 2019$0-100.0%N/AN/AN/A
    Dec 2018$160.57M-30.5%60.6%-314.9%-317.2%
    Dec 2017$230.98M+21.0%72.8%-59.7%-50.7%
    Dec 2016$190.93MN/A67.7%-65.6%-99.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$9.68M$3.92M$6.22M$26.91M$14.27M$31.99M$0$160.57M$230.98M$190.93M
    Cost of revenue$4.82M$4.27M$6.12M$6.34M$5.75M$5.37M$61.40M$63.29M$62.79M$61.64M
    Gross profit$4.86M-$342.00K$106.00K$20.57M$8.52M$26.62M-$61.40M$97.29M$168.19M$129.29M
    Research and development$41.33M$53.07M$48.61M$47.17M$47.93M$0$66.67M$404.59M$143.21M$112.14M
    Operating income-$110.51M-$135.03M-$99.76M-$75.73M-$91.95M$3.66M-$166.79M-$505.61M-$137.89M-$125.17M
    Net income-$250.64M-$126.23M-$95.90M$35.09M-$92.17M-$63.52M-$646.24M-$509.34M-$117.02M-$190.27M
    EBITDAN/A-$125.80M-$94.21M-$61.55M-$65.65M$31.06M-$129.99M-$349.06M-$97.94M-$38.93M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$74.15M$54.98M$23.25M$3.71M$2.92M$856.00K$1.34M$473.00K$953.00K$1.43M$1.06M$1.23M
    Gross profit$67.64M$52.17M$20.69M$2.11M$1.89M-$236.00K$241.00K-$696.00K-$56.00K$420.00K-$10.00K-$130.00K
    Operating income$38.65M$22.64M-$5.99M-$21.67M-$34.48M-$31.76M-$22.60M-$28.52M-$21.26M-$60.84M-$24.41M-$34.22M
    Net income$35.77M$20.07M-$7.93M-$23.50M-$146.34M-$26.64M-$54.15M-$19.73M-$23.98M-$58.79M-$23.74M-$33.06M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $94.31M exceeded cash and equivalents by $64.08M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$155.50M$145.27M$151.04M$215.98M$359.86M$314.59M$455.76M$716.18M$846.85M$949.07M
    Current assets$115.23M$102.41M$68.75M$118.16M$156.63M$148.95M$234.64M$285.48M$154.05M$315.18M
    Cash and equivalents$30.23M$29.52M$7.58M$4.86M$36.42M$51.79M$65.79M$96.88M$68.11M$62.61M
    Total liabilities$134.59M$78.53M$32.55M$89.72M$252.51M$247.41M$384.05M$337.45M$300.31M$379.82M
    Short-term debt$1.14M$956.00K$1.20M$43.22M$52.00K$360.00K$33.59M$945.00K$735.00K$1.21M
    Long-term debt$93.17M$0N/AN/A$179.88M$171.52M$186.32M$211.22M$7.54M$7.56M
    Shareholder equity$20.91M$38.51M$118.50M$126.26M$107.35M$67.17M$71.71M$362.86M$533.63M$560.24M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$212.10M$170.30M$138.63M$156.62M$171.26M$101.90M$128.79M$145.27M$83.47M$73.16M$134.85M$151.04M
    Total liabilities$128.31M$126.72M$118.39M$135.71M$129.40M$107.79M$113.33M$106.75M$28.10M$29.99M$37.83M$32.55M
    Cash and equivalents$14.96M$16.33M$7.48M$30.23M$14.32M$13.76M$6.06M$29.52M$24.73M$9.35M$17.48M$7.58M
    Shareholder equity$83.79M$43.58M$20.23M$20.91M$41.87M-$36.78M-$14.06M$38.51M$55.38M$43.17M$97.02M$118.50M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$87.83M-$68.17M-$66.93M-$65.05M-$55.77M-$77.02M-$135.93M-$124.24M-$103.72M-$48.99M
    Capital expenditures$2.00M$8.58M$1.54M$4.92M$7.25M$7.53M$37.88M$41.59M$46.67M$31.63M
    Free cash flow-$89.83M-$76.76M-$68.47M-$69.97M-$63.02M-$84.55M-$173.81M-$165.83M-$150.39M-$80.62M
    Dividends paidN/AN/AN/AN/AN/AN/AN/AN/A$913.00K$41.98M
    Share repurchasesN/AN/AN/AN/AN/A$0N/AN/A$10.00K$0
    Investing cash flow-$1.53M-$20.71M-$3.09M$226.42M-$74.54M$27.78M$86.85M-$151.21M$104.33M-$28.39M
    Financing cash flow$90.05M$110.58M$29.59M-$155.29M$121.19M$32.70M$8.14M$309.80M$4.28M$12.06M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$11.88M-$17.81M-$43.83M-$23.46M-$29.07M-$18.98M-$16.32M-$8.24M-$22.73M-$23.11M-$14.09M-$15.77M
    Capital expenditures$435.00K$392.00K$258.00K$18.00K$389.00K$966.00K$622.00K$1.03M$882.00K$2.32M$4.35M$1.04M
    Free cash flow$11.45M-$18.20M-$44.09M-$23.48M-$29.46M-$19.94M-$16.95M-$9.27M-$23.61M-$25.43M-$18.44M-$16.81M
    Last 12 quarters

    Frequently Asked Questions About PGEN

    What is Precigen's annual revenue?

    Precigen reported revenue of $9.68M for the fiscal year ended Dec 31, 2025.

    How fast is Precigen's revenue growing?

    Revenue was up 146.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -28.9%.

    Is Precigen profitable?

    No. Precigen reported net income of -$250.64M for the fiscal year ended Dec 31, 2025, with a net margin of -2588.2%.

    How much free cash flow does PGEN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$87.83M minus capital expenditures of $2.00M produced free cash flow of -$89.83M.

    How much debt does Precigen have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $93.17M, short-term debt of $1.14M and cash and equivalents of $30.23M.